Gastrointestinal effects and referred pain: The pronounced gastrointestinal side effects of GLP-1 therapyparticularly nausea, constipation, and abdominal distensioncan occasionally manifest as referred pain to the back
Retatrutide: The Triple Agonist in GLP-1 Research Retatrutide (LY3437943) is a once-weekly GLP-1/GIP/glucagon triple receptor agonist in Phase 3 trials demonstrating greater weight reduction than existing dual agonists
Its important to note that the direct effects of Ozempic on bone density are still being studied, and more research is needed to draw definitive conclusions. As for joint pain, while some users report experiencing discomfort, current evidence does not establish a direct link between Ozempic and joint or muscle pain
While GLP-1 medications were originally developed for type 2 diabetes, they are now widely used to manage obesity and metabolic syndrome
Factors like weight loss, stress, or dietary changes could also contribute
I started the Berberine Patch to support my Ozempic routine